Compounds & interventions

Estrogen

Medicine & Biotech · covered by 28 outlets this week · tracked since 2026-10-27

Press: 13 mainstream 45 specialist 30 independent outlet-days

What it is

Evidence 9/10 · thoroughly established Uneven · 2–10 by use Signals · signals observed in trials

Estrogen is the main female sex hormone, produced mostly by the ovaries until menopause, with roles in bone, heart, brain and skin as well as reproduction. Its medical uses are hormone therapy for menopause symptoms, contraception and gender-affirming care; in oncology, blocking it is the backbone of treatment for hormone-sensitive breast cancer. Coverage here spans the ongoing reassessment of menopausal hormone therapy, cancer-risk studies, and online communities trading dosing experiences.

The score describes menopausal hormone therapy and hormonal contraception, studied in large trials for decades, including the 2002 Women's Health Initiative. It does not cover unsupervised use for other purposes.

Evidence by use or claim · 1 preclinical to 10 thoroughly established

  1. Menopausal symptoms (hot flushes, night sweats)10/10 · thoroughly established

    The most effective treatment known; decades of trials.

  2. Hormonal contraception10/10 · thoroughly established

    In use since 1960; among the most studied medicines in existence.

  3. Osteoporosis prevention9/10 · thoroughly established

    The Women's Health Initiative confirmed fewer fractures.

  4. Heart disease prevention3/10 · early human evidence

    WHI found no benefit and harm in older starters; the timing hypothesis remains unproven.

  5. Dementia prevention2/10 · preclinical

    WHIMS found higher dementia risk when combined therapy was started after 65.

  • TrialThe Women's Health Initiative found combined estrogen plus progestin raised breast cancer, stroke and clot risk, mostly in women who started after 60 or more than ten years past menopause; estrogen alone did not raise breast cancer risk. source
  • TrialOral estrogen raises the risk of venous clots; transdermal and vaginal routes carry lower risk. source
  • RegulatorThe FDA has removed its long-standing boxed warnings for cardiovascular disease, breast cancer and dementia from some menopausal hormone products, reflecting the evidence that risk depends on age at starting. source
  • TrialA later WHI analysis linked combined therapy started after 65 to higher dementia risk; starting earlier has not shown that pattern. source

Written by the Alivewire editors from the coverage below, 3d ago; rated 2d ago. Not medical advice; how the ratings work.

Coverage

Estrogen
Reddit r/Biohackers · 5d ago